ALX Oncology Holdings Inc — Liquidità (NASDAQ:ALXO) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -38.29 M-68.1 M-89.22 M-130.36 M-121.91 M-84.14 M -84.14 M Flussi di cassa derivanti dalle attività di investimento 610 K-4.92 M-235.42 M44.66 M86.26 M82.59 M 82.59 M Liquidità derivante dalle attività di finanziamento 462.88 M2.47 M9.86 M59.29 M30.82 M362 K 362 K Liquidità libera -38.32 M-68.77 M-90.65 M-131.64 M-122.36 M-84.35 M -84.35 M

Notizie

ALX Oncology nomina Jeff Knight Chief Development Officer

Wells Fargo avvia copertura su ALX Oncology con rating overweight

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

IBRX Stock Jumps on Progress in NK Cell Therapy Production

JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study

RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study

RLMD Stock Surges 42% in a Week: Here's What You Should Know

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?